Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00997802 · ClinicalTrials.gov registry record · NA
Japanese National Computed Tomographic (CT) Colonography Trial
A NA study of Colonic Neoplasms and Colonic Polyps, sponsored by Japanese CT Colonography Society.
- Completed
- Registry status
- NA
- Development phase
- 1,257
- Enrollment target
- 12
- Study locations
NCT00997802: Completed NA study of Colonic Neoplasms and Colonic Polyps, sponsored by Japanese CT Colonography Society.
NCT00997802 is a NA study of Colonic Neoplasms and Colonic Polyps that has completed, run by Japanese CT Colonography Society. The registered enrollment target is 1,257 participants, below the 1,433-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (12% lower). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00997802, a NA study of Colonic Neoplasms and Colonic Polyps, has completed, sponsored by Japanese CT Colonography Society.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,257 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this study is to evaluate the sensitivity of computed tomographic colonography (CTC) in detecting colorectal polyps and cancers in 1,500 subjects at increased risk of colorectal cancer (CRC), using optical colonoscopy as the reference standard.
Conditions Studied
Interventions
- DEVICE CT colonography and optical colonoscopy
Study Locations (12)
Hokkaido
- Otarukyokai Hospital - Otaru
- Tonan Hospital - Sapporo
- Hokkaido Social Insurance Hospital - Sapporo
- Hokkaido Gastroenterology Hospital - Sapporo
Massachusetts
- Japanese CTC Society, 3D imaging Laboratory, Massachusetts General Hospital - Boston
Ishikawa-ken
- Kanazawa University Hospital - Kanazawa
Kanagawa
- Showa University Northern Yokohama Hospital - Yokohama
Nagasaki
- Kamigoto Hospital - Kamigotō
Okayama-ken
- Kawasaki Medical School - Kurashiki
Shizuoka
- Hamamatsu South Hospital - Hamamatsu
Tochigi
- Jichi Medical University Hospital - Shimono
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,257 participants |
| Start Date | 2009-10 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT00997802 record still lists
NCT00997802 is an interventional study that assigns participants to a tested intervention. Its 1,257 participants enrollment target places it among the larger protocols in the corpus, below the 1,433-participant average among 14 other Colonic Neoplasms trials with a reported enrollment target (12% lower).
The record links to 2 conditions, with Colonic Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which CT colonography and optical colonoscopy is the first listed.
NCT00997802 lists 12 locations in 9 states (Hokkaido, Massachusetts, Ishikawa-ken).
Frequently Asked Questions
What is clinical trial NCT00997802 about?
NCT00997802 is a clinical study titled "Japanese National Computed Tomographic (CT) Colonography Trial". The purpose of this study is to evaluate the sensitivity of computed tomographic colonography (CTC) in detecting colorectal polyps and cancers in 1,500 subjects at increased risk of colorectal cancer (CRC), using optical colonoscopy as the reference standard.
What is the current status of trial NCT00997802?
This trial is currently completed. It is a NA study. The enrollment target is 1,257 participants. The study started on 2009-10. Estimated completion is 2017-01.
What conditions does trial NCT00997802 study?
This clinical trial studies the following conditions: Colonic Neoplasms, Colonic Polyps.
What interventions are being tested in trial NCT00997802?
The interventions under investigation include: CT colonography and optical colonoscopy (DEVICE).
Who is sponsoring clinical trial NCT00997802?
This trial is sponsored by Japanese CT Colonography Society, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00997802 being conducted?
This trial has 12 study locations across Massachusetts, Hokkaido, Ishikawa-ken, Kanagawa, Nagasaki. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonic Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00997802's enrollment target sits among peer trials
1,257 3rd of 14 higher than 12 of 14 other Colonic Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonic Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Strategies for Optimizing a Mailed FIT Program in Appalachia
RECRUITING · NA
-
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
RECRUITING · NA
-
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer
RECRUITING · NA
-
Mailed FIT Outreach to Improve Colon Cancer Screening in the Safety-net System
COMPLETED · NA
-
Trial of a Computer-Based Presentation of Quantitative Information About Colorectal Cancer Screening
COMPLETED · NA
-
Case Series With Saneso 3600 Colonoscope
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- NCT06812273 · 1,260 participants · NA
Mediators and Moderators of Auditory Training
- NCT06931340 · 1,260 participants · Phase 3
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia